Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03589599 · ClinicalTrials.gov registry record · NA

Understanding the Effect of Flavor on Hookah Smoking Experience

A NA study of Waterpipe Smoking, sponsored by Florida International University.

Completed
Registry status
NA
Development phase
144
Enrollment target
1
Study location

NCT03589599: Completed NA study of Waterpipe Smoking, sponsored by Florida International University.

NCT03589599 is a NA study of Waterpipe Smoking that has completed, run by Florida International University. The registered enrollment target is 144 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03589599, a NA study of Waterpipe Smoking, has completed, sponsored by Florida International University.

COMPLETED
Registry status
NA
Development phase
144 participants
Enrollment target
1
Study location

Study Summary

This project addresses the need for evidence about the effect of flavoring manipulation on waterpipe smokers' satisfaction, dependence, harm perception, and toxicants exposure. Specifically, in this clinical study investigators will compare the effect on flavored and non-flavored waterpipe tobacco on smoking behavior, subjective experiences and toxicant exposure among waterpipe users. Findings from this study will help informing flavor-based product regulation by the FDA.

Primary Outcome

Change in plasma nicotine level

Conditions Studied

Interventions

  • OTHER Flavored tobacco
  • OTHER Non-flavored tobacco

Study Locations (1)

Florida

  • Florida International University - Miami

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2017-03-21
Est. Completion 2020-06-30
Phase NA
Florida International University

89 total trials

What the finished NCT03589599 record still lists

NCT03589599 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Waterpipe Smoking appearing as the primary indexed condition, and to 2 interventions - of which Flavored tobacco is the first listed.

NCT03589599 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT03589599 about?

NCT03589599 is a clinical study titled "Understanding the Effect of Flavor on Hookah Smoking Experience". This project addresses the need for evidence about the effect of flavoring manipulation on waterpipe smokers' satisfaction, dependence, harm perception, and toxicants exposure. Specifically, in this clinical study investigators will compare the effect on flavored and non-flavored waterpipe tobacco o...

What is the current status of trial NCT03589599?

This trial is currently completed. It is a NA study. The enrollment target is 144 participants. The study started on 2017-03-21. Estimated completion is 2020-06-30.

What conditions does trial NCT03589599 study?

This clinical trial studies the following conditions: Waterpipe Smoking.

What interventions are being tested in trial NCT03589599?

The interventions under investigation include: Flavored tobacco (OTHER), Non-flavored tobacco (OTHER).

Who is sponsoring clinical trial NCT03589599?

This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03589599 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT03589599's enrollment target sits among peer trials

144 706th of 2000 higher than 1,290 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03589599, the US trial registry maintained by the National Library of Medicine. NCT03589599 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.